Based on the above results, we could preliminarily draw the following conclusion: Transcription factor ELF4 may alleviate inflammatory bowel disease by activating IL1RN transcription to suppress the inflammatory activity of TH17 cells and inducing M2 polarization of macrophages (Figure 6). The gene discussed is ELF4; the disease is inflammatory bowel disease.